Advisory Committee on Immunization Practices (ACIP), 60877-60878 [2013-24061]

Download as PDF Federal Register / Vol. 78, No. 191 / Wednesday, October 2, 2013 / Notices 60877 DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Advisory Committee on Immunization Practices (ACIP) Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. The meeting announced below concerns Occupational Safety and Health Training Project Grants (T03), PAR–10–288, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 8 a.m.–5 p.m., November 6, 2013 (Closed). Place: Centers for Disease Control and Prevention, Roybal Campus, Building 19–GCC, 1600 Clifton Road, Atlanta, Georgia 30333, Telephone: (404) 639– 6000. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Occupational Safety and Health Training Project Grants (T03) PAR–10– 288.’’ Joan F. Karr, Ph.D., Scientific Review Officer, CDC/NIOSH 1600 Clifton Road, Mailstop E–74, Atlanta, Georgia 30333, Telephone: (404) 498–2506. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. tkelley on DSK3SPTVN1PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–24065 Filed 10–1–13; 8:45 am] BILLING CODE 4163–18–P VerDate Mar<15>2010 17:48 Oct 01, 2013 Jkt 232001 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting of the aforementioned committee: Times and Dates: 8:00 a.m.–5:45 p.m., October 23, 2013. 8:00 a.m.–1:00 p.m., October 24, 2013. Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton Road NE., Building 19, Kent ‘‘Oz’’ Nelson Auditorium, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Meeting is webcast live via the World Wide Web; for instructions and more information on ACIP please visit the ACIP Web site: http://www.cdc.gov/vaccines/ acip/index.html. Purpose: The committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Further, under provisions of the Affordable Care Act, at section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been adopted by the Director of the Centers for Disease Control and Prevention must be covered by applicable health plans. Matters To Be Discussed: The agenda will include discussions on: child/adolescent immunization schedule, adult immunization schedule, meningococcal vaccines, pneumococcal conjugate vaccine, herpes zoster vaccine, tetanus, diphtheria and acellular pertussis vaccine, yellow fever vaccine, global immunization update, human papillomavirus vaccines, general recommendations on immunizations, and influenza. Recommendation votes are scheduled for child/adolescent immunization schedule, adult immunization schedule, and meningococcal vaccines. Time will be available for public comment. Agenda items are subject to change as priorities dictate. Contact Person For More Information: Felicia Betancourt, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road NE., MS–A27, Atlanta, Georgia 30333, telephone 404/639– 8836; Email ACIP@CDC.GOV. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 [FR Doc. 2013–24068 Filed 10–1–13; 8:45 am] BILLING CODE 4160–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) In accordance with section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting of the aforementioned committee: Times and Dates: 8 a.m.–5:45 p.m., October 23, 2013; 8 a.m.–1 p.m., October 24, 2013. Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton Road NE., Building 19, Kent ‘‘Oz’’ Nelson Auditorium, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Meeting is Webcast live via the World Wide Web; for instructions and more information on ACIP please visit the ACIP Web site: http://www.cdc.gov/vaccines/ acip/index.html. Purpose: The committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Further, under provisions of the Affordable Care Act, at section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been adopted by the Director of the Centers for Disease Control and Prevention must be covered by applicable health plans. Matters To Be Discussed: The agenda will include discussions on: child/adolescent immunization schedule, adult immunization schedule, meningococcal vaccines, pneumococcal conjugate vaccine, herpes zoster vaccine, tetanus, diphtheria and acellular pertussis vaccine, yellow fever vaccine, global immunization update, human papillomavirus vaccines, general recommendations on immunizations, and influenza. Recommendation votes are scheduled for child/adolescent immunization schedule, adult immunization schedule, and meningococcal vaccines. Time will be available for public comment. Agenda items are subject to change as priorities dictate. E:\FR\FM\02OCN1.SGM 02OCN1 60878 Federal Register / Vol. 78, No. 191 / Wednesday, October 2, 2013 / Notices For Further Information Contact: Felicia Betancourt, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road NE., MS–A27, Atlanta, Georgia 30333, telephone 404/639– 8836; Email ACIP@CDC.GOV The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–24061 Filed 10–1–13; 8:45 am] Officer, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488–3585, Email: EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Telephone: (770) 488–3585, Email: EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–24062 Filed 10–1–13; 8:45 am] BILLING CODE 4163–18–P [FR Doc. 2013–24067 Filed 10–1–13; 8:45 am] BILLING CODE 4160–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review tkelley on DSK3SPTVN1PROD with NOTICES The meeting announced below concerns Health Promotion and Disease Prevention Research Centers, Funding Opportunity Announcement (FOA) DP14–001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times and Dates 8 a.m.–6:30 p.m., November 18, 2013 (Closed) 8 a.m.–6:30 p.m., November 19, 2013 (Closed) 8 a.m.–6:30 p.m., November 20, 2013 (Closed) 8 a.m.–6:30 p.m., November 21, 2013 (Closed) Place: Centers for Disease Control and Prevention, 1600 Clifton Road NE., Global Communications Center, Auditorium B, Atlanta, Georgia 30333. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Health Promotion and Disease Prevention Research Centers, FOA DP14–001’’. For Further Information Contact: M. Chris Langub, Ph.D., Scientific Review VerDate Mar<15>2010 17:48 Oct 01, 2013 Jkt 232001 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Health Promotion and Disease Prevention Research Centers, Funding Opportunity Announcement (FOA) DP14–001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times And Dates 8 a.m.–6:30 p.m., November 18, 2013 (Closed); 8 a.m.–6:30 p.m., November 19, 2013 (Closed); 8 a.m.–6:30 p.m., November 20, 2013 (Closed); 8 a.m.– 6:30 p.m., November 21, 2013 (Closed). Place: Centers for Disease Control and Prevention, 1600 Clifton Road NE., Global Communications Center, Auditorium B, Atlanta, Georgia 30333. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Health Promotion and Disease Prevention Research Centers, FOA DP14–001’’. For Further Information Contact: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns National Center for Construction Safety and Health Research and Translation (U60, Request for Application (RFA) OH13–001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 8 a.m.–5 p.m., November 19, 2013 (Closed); 8 a.m.–5 p.m., November 20, 2013 (Closed); 8 a.m.–12 p.m., November 21, 2013 (Closed). Place: Embassy Suites Alexandria Hotel, 1900 Diagonal Road, Alexandria, Virginia 22314, Telephone: (703)842– 7030. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘National Center for Construction Safety and Health Research and Translation (U60), RFA OH13–001.’’ For Further Information Contact: George Bockosh, M.S., Scientific Review Officer, CDC/NIOSH, 626 Cochrans Mill Road, Mailstop P–05, Pittsburgh, Pennsylvania 15236, Telephone: (412) E:\FR\FM\02OCN1.SGM 02OCN1

Agencies

[Federal Register Volume 78, Number 191 (Wednesday, October 2, 2013)]
[Notices]
[Pages 60877-60878]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-24061]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    In accordance with section 10(a) (2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting of the aforementioned 
committee:

    Times and Dates: 8 a.m.-5:45 p.m., October 23, 2013; 8 a.m.-1 
p.m., October 24, 2013.
    Place: CDC, Tom Harkin Global Communications Center, 1600 
Clifton Road NE., Building 19, Kent ``Oz'' Nelson Auditorium, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available. 
Meeting is Webcast live via the World Wide Web; for instructions and 
more information on ACIP please visit the ACIP Web site: http://www.cdc.gov/vaccines/acip/index.html. Purpose: The committee is 
charged with advising the Director, CDC, on the appropriate uses of 
immunizing agents. In addition, under 42 U.S.C. 1396s, the committee 
is mandated to establish and periodically review and, as 
appropriate, revise the list of vaccines for administration to 
vaccine-eligible children through the Vaccines for Children (VFC) 
program, along with schedules regarding the appropriate periodicity, 
dosage, and contraindications applicable to the vaccines. Further, 
under provisions of the Affordable Care Act, at section 2713 of the 
Public Health Service Act, immunization recommendations of the ACIP 
that have been adopted by the Director of the Centers for Disease 
Control and Prevention must be covered by applicable health plans.
    Matters To Be Discussed: The agenda will include discussions on: 
child/adolescent immunization schedule, adult immunization schedule, 
meningococcal vaccines, pneumococcal conjugate vaccine, herpes 
zoster vaccine, tetanus, diphtheria and acellular pertussis vaccine, 
yellow fever vaccine, global immunization update, human 
papillomavirus vaccines, general recommendations on immunizations, 
and influenza. Recommendation votes are scheduled for child/
adolescent immunization schedule, adult immunization schedule, and 
meningococcal vaccines. Time will be available for public comment. 
Agenda items are subject to change as priorities dictate.

[[Page 60878]]

    For Further Information Contact: Felicia Betancourt, National 
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton 
Road NE., MS-A27, Atlanta, Georgia 30333, telephone 404/639-8836; 
Email ACIP@CDC.GOV
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2013-24061 Filed 10-1-13; 8:45 am]
BILLING CODE 4160-18-P